美国前列腺癌筛查中前列腺特异性抗原检测的最新模式。
Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States.
机构信息
Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
Office of the Chief Medical Officer, American Cancer Society, Atlanta, Georgia.
出版信息
JAMA Intern Med. 2017 Jul 1;177(7):1040-1042. doi: 10.1001/jamainternmed.2017.0340.
Abstract
This study of National Health Interview Survey data evaluates recent patterns of prostate-specific antigen testing for prostate cancer screening in the United States
摘要
本研究利用国家健康访谈调查数据评估了美国近期前列腺特异性抗原检测用于前列腺癌筛查的模式。
相似文献
1
Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States.美国前列腺癌筛查中前列腺特异性抗原检测的最新模式。
JAMA Intern Med. 2017 Jul 1;177(7):1040-1042. doi: 10.1001/jamainternmed.2017.0340.
2
Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.在基层医疗的现实世界中开展前列腺癌筛查：海市蜃楼与流沙
JAMA Oncol. 2018 Apr 1;4(4):453-454. doi: 10.1001/jamaoncol.2017.5682.
3
Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.美国预防服务工作组（USPSTF）对前列腺特异性抗原筛查的D级推荐的长期后果。
Cancer. 2020 Feb 15;126(4):694-696. doi: 10.1002/cncr.32605. Epub 2019 Dec 3.
4
Prostate cancer screening practices in a large, integrated health system: 2007-2014.大型综合医疗系统中的前列腺癌筛查实践：2007 - 2014年
BJU Int. 2017 Aug;120(2):257-264. doi: 10.1111/bju.13793. Epub 2017 Feb 26.
5
US guideline may have led to drop in PSA testing among primary care physicians, studies find.研究发现，美国指南可能导致基层医疗医生进行前列腺特异抗原（PSA）检测的次数减少。
BMJ. 2015 May 28;350:h2906. doi: 10.1136/bmj.h2906.
6
Relevance of total PSA and free PSA prescriptions.总前列腺特异抗原（PSA）和游离PSA检测指标的相关性。
Ann Biol Clin (Paris). 2018 Dec 1;76(6):659-663. doi: 10.1684/abc.2018.1392.
7
Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer?有下尿路症状的男性患晚期前列腺癌的风险会增加吗？
BMJ. 2018 May 3;361:k1202. doi: 10.1136/bmj.k1202.
8
Prostate cancer screening in New Zealand.新西兰的前列腺癌筛查
N Z Med J. 2013 Sep 27;126(1383):94.
9
Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians.重新审视佛蒙特州初级保健医生的前列腺癌筛查实践。
J Community Health. 2018 Feb;43(1):33-37. doi: 10.1007/s10900-017-0384-x.
10
Evolving detection and treatment methods change approaches to prostate cancer: US Preventive Services Task Force draft recommendations now align more closely with others.不断发展的检测和治疗方法改变了前列腺癌的治疗方式：美国预防服务工作组的建议草案现在与其他建议更为一致。
Cancer. 2018 Jan 1;124(1):11-12. doi: 10.1002/cncr.31180.
引用本文的文献
1
Increased GPR35 expression is correlated with poor prognosis in prostate cancer.GPR35表达增加与前列腺癌预后不良相关。
World J Surg Oncol. 2025 Jun 18;23(1):239. doi: 10.1186/s12957-025-03893-0.
2
Global insight of early-onset genitourinary cancers in adolescents and adults from 1990 to 2021: temporal trends and health inequalities analyses.1990年至2021年青少年及成人早发性泌尿生殖系统癌症的全球洞察：时间趋势与健康不平等分析
World J Surg Oncol. 2025 May 31;23(1):208. doi: 10.1186/s12957-025-03849-4.
3
Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000-2020.2000-2020 年期间，在美国一家城市 HIV 诊所登记的 HIV 感染者中，影响前列腺癌筛查的因素。
Prev Med. 2024 Jul;184:108000. doi: 10.1016/j.ypmed.2024.108000. Epub 2024 May 10.
4
The Impact of Prostate-Specific Antigen Screening on Prostate Cancer Incidence and Mortality in China: 13-Year Prospective Population-Based Cohort Study.前列腺特异性抗原筛查对中国前列腺癌发病率和死亡率的影响：基于人群的13年前瞻性队列研究
JMIR Public Health Surveill. 2024 Jan 18;10:e47161. doi: 10.2196/47161.
5
Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.USPSTF 不推荐前列腺特异性抗原筛查等级 D 与前列腺癌特异性死亡率的关联。
JAMA Netw Open. 2022 May 2;5(5):e2211869. doi: 10.1001/jamanetworkopen.2022.11869.
6
Number of prostate-specific antigen (PSA) screening tests in the last five years reported by men in the United States in 2010, 2015, and 2018.2010 年、2015 年和 2018 年，美国男性报告的过去五年中进行的前列腺特异性抗原（PSA）筛查测试次数。
Urol Oncol. 2022 May;40(5):192.e19-192.e25. doi: 10.1016/j.urolonc.2022.01.016. Epub 2022 Feb 27.
7
Landscape of Immunotherapy in Genitourinary Malignancies.泌尿生殖系统恶性肿瘤的免疫治疗全景。
Adv Exp Med Biol. 2021;1342:143-192. doi: 10.1007/978-3-030-79308-1_5.
8
Contributions of Social Factors to Disparities in Prostate Cancer Risk Profiles among Black Men and Non-Hispanic White Men with Prostate Cancer in California.社会因素对加利福尼亚州有前列腺癌的黑人和非西班牙裔白种男性前列腺癌风险特征差异的影响。
Cancer Epidemiol Biomarkers Prev. 2022 Feb;31(2):404-412. doi: 10.1158/1055-9965.EPI-21-0697. Epub 2021 Nov 30.
9
Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019.全球、区域和国家的肾脏、膀胱和前列腺癌负担及其归因风险因素，1990-2019 年。
Mil Med Res. 2021 Nov 24;8(1):60. doi: 10.1186/s40779-021-00354-z.
10
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.《全国癌症状况年度报告》第 1 部分：国家癌症统计。
J Natl Cancer Inst. 2021 Nov 29;113(12):1648-1669. doi: 10.1093/jnci/djab131.
本文引用的文献
1
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.美国前列腺癌诊断时远处转移的增加。
JAMA Oncol. 2017 May 1;3(5):705-707. doi: 10.1001/jamaoncol.2016.5465.
2
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.与 USPSTF 筛查建议相关的前列腺癌发病率和 PSA 检测模式。
JAMA. 2015 Nov 17;314(19):2054-61. doi: 10.1001/jama.2015.14905.
3
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查：美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459.
4
American Cancer Society guideline for the early detection of prostate cancer: update 2010.美国癌症协会前列腺癌早期检测指南：2010 年更新版。
CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. doi: 10.3322/caac.20066. Epub 2010 Mar 3.
5
Accuracy of self-reported cancer-screening histories: a meta-analysis.自我报告的癌症筛查史的准确性：一项荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):748-57. doi: 10.1158/1055-9965.EPI-07-2629. Epub 2008 Apr 1.
Zotero 插件